|
(PQ#3) Novel tumor intrinsic PD-L1 signals direct tumor immune cell infiltration
|
5R01CA205965-02
|
$640,839
|
|
CURIEL, TYLER
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
|
5R01CA206025-03
|
$630,724
|
|
GUISE, THERESA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
(PQ1) Characterization of Premalignant Fields in a Murine Model of Head and Neck and Esophageal Cancers
|
5R01CA205258-03
|
$464,261
|
|
GUDAS, LORRAINE
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
(PQ1) Genomic characterization of mesenchymal stromal cells in Monoclonal Gammopathy of Undermined Significance (MGUS)
|
5R01CA205954-03
|
$703,249
|
|
GHOBRIAL, IRENE
|
DANA-FARBER CANCER INST
|
|
(PQ1) GUCY2C hormone loss translates APC-Beta-catenin mutations into epithelial transformation
|
5R01CA206026-03
|
$356,850
|
|
WALDMAN, SCOTT
|
THOMAS JEFFERSON UNIVERSITY
|
|
(PQ1) Lipid Metabolism, Inflammation, and T cell Dysfunction in HIV-associated Cancer
|
5R01CA206483-02
|
$570,958
|
|
EMU, BRINDA
|
YALE UNIVERSITY
|
|
(PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection
|
5R01CA206476-03
|
$706,386
|
|
CHIAO, ELIZABETH
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer
|
5R01CA206465-03
|
$512,833
|
|
JUSTICE, AMY
|
YALE UNIVERSITY
|
|
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression
|
5R01CA194461-04
|
$334,291
|
|
PARK, KWON-SIK
|
UNIVERSITY OF VIRGINIA
|
|
(PQ5) Effect of HIV infection on viral and host gene expression and antitumor immunity in Kaposi Sarcoma in Africa
|
5R01CA217138-02
|
$723,817
|
|
WARREN, EDUS
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
(PQ5) Informing anal neoplasia differences/similarities in HIV-serodiscordant individuals
|
5R21CA216830-02
|
$192,500
|
|
SHIRAMIZU, BRUCE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
(PQ8) Genetically faithful murine models for studying disease progression in chronic lymphocytic leukemia
|
5R01CA216273-02
|
$740,321
|
|
WU, CATHERINE
|
DANA-FARBER CANCER INST
|
|
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors
|
5R01CA194470-04
|
$446,627
|
|
JANES, KEVIN
|
UNIVERSITY OF VIRGINIA
|
|
(PQD-3) Spatiotemporal Molecular Interrogation of Early Metastatic Evolution In Situ
|
5R01CA194697-04
|
$347,700
|
|
ZHANG, SIYUAN
|
UNIVERSITY OF NOTRE DAME
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
$24,762
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
53BP1-dependent pathway in DNA repair
|
5R01CA216437-02
|
$1
|
|
CHEN, JUNJIE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
A blood test to identify prostate cancer patients at risk for visceral metastasis
|
5R01CA218356-02
|
$601,750
|
|
POSADAS, EDWIN
|
CEDARS-SINAI MEDICAL CENTER
|
|
A cluster randomized trial of a primary palliative care intervention (CONNECT) for patients with advanced cancer
|
5R01CA197103-03
|
$584,861
|
|
SCHENKER, YAEL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
A genomewide discovery of chemoresistance-associated noncoding RNAs in human cancers
|
1R21CA226303-01
|
$176,175
|
|
HE, TONG-CHUAN
|
UNIVERSITY OF CHICAGO
|
|
A High-Throughput Model for Human Melanoma
|
5R01CA121118-10
|
$247,340
|
|
HOLMEN, SHERI
|
UNIVERSITY OF UTAH
|
|
A Label-Free, Point-of-Care Platform to Diagnose Acute Promyelocytic Leukemia
|
5R01CA190843-03
|
$311,458
|
$155,729
|
SOHN, LYDIA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
A longitudinal assessment of frailty in young adult survivors of childhood cancer
|
5R01CA174851-05
|
$511,226
|
|
NESS, KIRSTEN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
A microRNA mediating vascular directed fibrinolysis and tumor progression
|
5F31CA213793-03
|
$33,794
|
|
MCCANN, JAMES
|
UNIVERSITY OF VIRGINIA
|
|
A new imaging approach to radiotherapy planning for lung cancer
|
5R01CA193050-04
|
$577,910
|
|
RIZI, RAHIM
|
UNIVERSITY OF PENNSYLVANIA
|
|
A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors
|
5R01CA217956-02
|
$688,403
|
|
BRADY-KALNAY, SUSANN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
A novel N-Ras pathway driving DCIS to basal-like breast cancer
|
1R21CA226567-01
|
$212,055
|
|
CHANG, ERIC
|
BAYLOR COLLEGE OF MEDICINE
|
|
A novel T-cell subset able to kill relapsed cancers
|
5R01CA200539-03
|
$362,569
|
|
YI, QING
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
A Phase I trial combining IV fenretinide and IV safingol to target overproduction
|
5R44CA183316-03
|
$473,425
|
|
SIMPSON, WILLIAM
|
CERRX, INC.
|
|
A Randomized Controlled Trial of an HPV Vaccine Intervention for Young Sexual Minority Men
|
1R37CA226682-01
|
$602,822
|
|
REITER, PAUL
|
OHIO STATE UNIVERSITY
|
|
A role for notch in self renewal in embryonal rhabdomyosarcoma
|
5R00CA175184-04
|
$249,000
|
|
IGNATIUS, MYRON
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
A SIGNALING PATHWAY SPECIFIC FOR ALKYLATION DAMAGE
|
1R01CA227001-01
|
$355,706
|
|
MOSAMMAPARAST, NIMA
|
WASHINGTON UNIVERSITY
|
|
A Target-Directed Reagent Pipeline via Microfluidic mRNA Display
|
5R21CA204708-02
|
$191,186
|
|
MALMSTADT, NOAH
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
A Targeted Nanomedicine Prototype Against Enzalutamide-resistant Prostate Cancer
|
1R01CA226537-01
|
$673,092
|
|
PASQUALINI, RENATA
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
A Vascularized, In Vitro, Organotropic Metastasis Model to Generate Dormant Micrometastases
|
5R21CA214299-02
|
$181,477
|
|
SLATER, JOHN
|
UNIVERSITY OF DELAWARE
|
|
A versatile high-performance optical mammography co-imager
|
5R01CA204443-03
|
$343,021
|
|
FANG, QIANQIAN
|
NORTHEASTERN UNIVERSITY
|
|
ABCD-USA Consortium: Coordinating Center
|
5U24DA041147-04
|
$750,000
|
|
JERNIGAN, TERRY
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
ABCD-USA Consortium: Data Analysis Center
|
5U24DA041123-04
|
$750,000
|
|
DALE, ANDERS
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Aberrant DNA methylation patterns of miRNAs and breast cancer racial disparities
|
5K07CA178293-05
|
$143,992
|
|
GONG, ZHIHONG
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S1
|
$125,000
|
$1,250
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S2
|
$62,491
|
$625
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-41
|
$7,810,244
|
$78,102
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Accounting for and harnessing RBE variability in proton therapy
|
1R01CA225961-01
|
$289,506
|
|
VASSILIEV, OLEG
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Achieving Excellence in Biopsychosocial Cancer Pain Management through a Comprehensive Quality Education Program
|
1R25CA225485-01
|
$262,605
|
|
DY, SYDNEY
|
JOHNS HOPKINS UNIVERSITY
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$380,330
|
$190,165
|
Aplan, Peter
|
CCR (NCI)
|
|
Addressing ELSI Issues in Unregulated Health Research Using Mobile Devices
|
5R01CA207538-02
|
$247,350
|
|
ROTHSTEIN, MARK
|
UNIVERSITY OF LOUISVILLE
|
|
Adhesive regulation during cell migration
|
5R01CA085862-19
|
$319,787
|
|
HUTTENLOCHER, ANNA
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Adipocytes are Important Players in the Acute Lymphoblastic Leukemia Microenvironment
|
7R01CA201444-02
|
$396,181
|
$396,181
|
MITTELMAN, STEVEN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Adipose stromal cell targeting: a new approach to breast cancer treatment
|
1R21CA216745-01A1
|
$182,479
|
|
KOLONIN, MIKHAIL
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
|
Adoptive T cell Therapy for Pediatric Leukemia
|
ZIA BC 011565
|
$776,399
|
$776,399
|
Fry, Terry
|
CCR (NCI)
|
|
Adult Leukemia Research Center
|
2P01CA018029-42A1
|
$3,990,001
|
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Total relevant funding to Childhood Leukemia for this search: $70,034,624
|